[go: up one dir, main page]

AU2001267504A1 - Nasal ointment based on white petroleum jelly - Google Patents

Nasal ointment based on white petroleum jelly

Info

Publication number
AU2001267504A1
AU2001267504A1 AU2001267504A AU6750401A AU2001267504A1 AU 2001267504 A1 AU2001267504 A1 AU 2001267504A1 AU 2001267504 A AU2001267504 A AU 2001267504A AU 6750401 A AU6750401 A AU 6750401A AU 2001267504 A1 AU2001267504 A1 AU 2001267504A1
Authority
AU
Australia
Prior art keywords
petroleum jelly
white petroleum
nasal ointment
ointment based
nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267504A
Inventor
Peter Theiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHYT-IMMUN GmbH
Original Assignee
PHYT IMMUN GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHYT IMMUN GmbH filed Critical PHYT IMMUN GmbH
Publication of AU2001267504A1 publication Critical patent/AU2001267504A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A nasal ointment contains a mixture of saturated hydrocarbons with a viscosity according to DIN 51 562 of above 6 mm<2>/s (100 degrees C). The ointment can also contain additives which confer a soothing/healing effect.
AU2001267504A 2000-05-31 2001-05-31 Nasal ointment based on white petroleum jelly Abandoned AU2001267504A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE20009841 2000-05-31
DE20009841U DE20009841U1 (en) 2000-05-31 2000-05-31 Vaseline-based nasal ointment
PCT/EP2001/006197 WO2001091719A1 (en) 2000-05-31 2001-05-31 Nasal ointment based on white petroleum jelly

Publications (1)

Publication Number Publication Date
AU2001267504A1 true AU2001267504A1 (en) 2001-12-11

Family

ID=7942316

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267504A Abandoned AU2001267504A1 (en) 2000-05-31 2001-05-31 Nasal ointment based on white petroleum jelly

Country Status (19)

Country Link
US (3) US20030161899A1 (en)
EP (2) EP1159958A1 (en)
JP (2) JP2001342131A (en)
KR (1) KR20030030998A (en)
AT (1) ATE493112T1 (en)
AU (1) AU2001267504A1 (en)
BG (1) BG64887B1 (en)
BR (1) BR0003852A (en)
CA (1) CA2413188A1 (en)
CZ (1) CZ296192B6 (en)
DE (2) DE20009841U1 (en)
EE (1) EE04769B1 (en)
HR (1) HRP20000559A2 (en)
HU (1) HUP0003408A2 (en)
PL (1) PL198950B1 (en)
RU (1) RU2237468C2 (en)
SK (1) SK286019B6 (en)
UA (1) UA72734C2 (en)
WO (1) WO2001091719A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20009841U1 (en) * 2000-05-31 2001-10-25 Phyt-Immun GmbH, 66424 Homburg Vaseline-based nasal ointment
JP4614423B2 (en) * 2004-04-30 2011-01-19 フマキラー株式会社 Nasal composition for allergic rhinitis
JP2006008516A (en) * 2004-06-21 2006-01-12 Nippon Kenko Kagaku Kenkyu Center:Kk Nasal pollen allergy prevention ointment and nostril pollen allergy prevention ointment
JP2006312635A (en) * 2005-04-08 2006-11-16 Hinode Sangyo Kk Nasal wall coating composition
NL2001342C2 (en) * 2008-02-20 2009-08-24 Cornelis Boegem Balm for covering mucous membranes against allergenic substances present in the air, the use of the balm and an applicator for the balm.
JP5337984B2 (en) * 2008-11-07 2013-11-06 アース製薬株式会社 Intranasal preparation and method for preventing sagging in nasal cavity
WO2013049539A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. A method of blocking or trapping allergens
CN112076148B (en) * 2019-06-12 2025-01-10 陕西佰傲再生医学有限公司 Antiallergic gel for nasal use and preparation method thereof
AU2020230306A1 (en) * 2020-09-10 2022-03-24 Dao Cheng Song It is a method to suppress/cure hay fever. Having some moisturiser (Lip Balm, Papaw Ointment) to wax around the inner nose it can effectively suppress hay fever. This invention is a guide for any manufacture interested in creating a product that consists of a similar type of ingredients and creating a specialised medical item, designed a sole purpose for coping hay fever.
JP7074388B1 (en) * 2022-01-25 2022-05-24 株式会社オフィスシステムサービス External nasal agent

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2095092A (en) * 1936-02-21 1937-10-05 Clorox Chemical Co Ointment
DE3010572C2 (en) * 1980-03-19 1982-05-06 Süess, Hans R., Dr., Starrkirch Skin care and skin protection preparations
DE3416209A1 (en) * 1984-05-02 1985-11-21 Mohamed Roshdy Dr Ismail EYE TREATMENT PREPARATIONS
EP0316633B1 (en) * 1987-11-13 1993-01-27 ASTA Medica Aktiengesellschaft Medicine containing azelastine for application in the nose and/or at the eye
DK0482208T3 (en) * 1990-04-25 2000-09-18 Nissan Chemical Ind Ltd Pyridazinone derivatives
DE4117887C2 (en) * 1990-06-09 1993-12-16 Siegfried Rochler Use of pharmaceutically / cosmetically defined petroleum jelly as a nasal ointment for the prophylaxis of inhalation allergic reactions
HUT63060A (en) * 1991-08-22 1993-07-28 Hoechst Ag Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists
RU2038071C1 (en) * 1992-12-15 1995-06-27 Дейгин Владислав Исакович Face skin cream
DE4438589A1 (en) * 1994-10-28 1995-03-23 Reingard Dr Muenster Nasal therapeutic agent
DE19544905A1 (en) * 1995-12-01 1997-06-05 Robugen Gmbh Preparation of plant extracts
US5972327A (en) * 1997-10-22 1999-10-26 Lin; Matthew M. Method of treating allergic rhinitis by delivering medication via the nasal vestibules
JPH11246416A (en) * 1998-03-05 1999-09-14 Nof Corp Nasal drop additive and nasal drop
DE20002395U1 (en) * 2000-02-13 2000-05-25 Febena Pharma GmbH, 50825 Köln Cream, especially for external use on the nasal skin
DE20009841U1 (en) * 2000-05-31 2001-10-25 Phyt-Immun GmbH, 66424 Homburg Vaseline-based nasal ointment

Also Published As

Publication number Publication date
BG64887B1 (en) 2006-08-31
EP1159958A1 (en) 2001-12-05
HRP20000559A2 (en) 2001-12-31
US20020082305A1 (en) 2002-06-27
WO2001091719A1 (en) 2001-12-06
BR0003852A (en) 2002-07-23
EE04769B1 (en) 2007-02-15
HUP0003408A2 (en) 2002-09-28
JP2006316063A (en) 2006-11-24
SK12812000A3 (en) 2001-12-03
EP1286657A1 (en) 2003-03-05
PL342179A1 (en) 2001-12-03
DE20009841U1 (en) 2001-10-25
SK286019B6 (en) 2008-01-07
JP2001342131A (en) 2001-12-11
HU0003408D0 (en) 2000-08-25
DE50115757D1 (en) 2011-02-10
US20120308671A1 (en) 2012-12-06
EE200000375A (en) 2002-02-15
ATE493112T1 (en) 2011-01-15
BG104714A (en) 2002-05-31
RU2237468C2 (en) 2004-10-10
CZ296192B6 (en) 2006-02-15
US20030161899A1 (en) 2003-08-28
KR20030030998A (en) 2003-04-18
UA72734C2 (en) 2005-04-15
CA2413188A1 (en) 2001-12-06
PL198950B1 (en) 2008-08-29
EP1286657B1 (en) 2010-12-29
CZ20003062A3 (en) 2002-01-16

Similar Documents

Publication Publication Date Title
GEP20104997B (en) Composition comprising anther2 antibodies
IL136591A0 (en) Nasal solutions
BR0112093A (en) Sulphonyl pyrrolidine derivatives useful in the treatment of neurological disorders
BR0113162A (en) Non-imidazole Aryloxyalkylamines
MXPA05008524A (en) Pyrazoles and methods of making and using the same.
AU2001267504A1 (en) Nasal ointment based on white petroleum jelly
MY122262A (en) Lh-rh peptide analogues their uses and pharmaceutical compositions containing them
BR9916680A (en) Derivatives of 3,3-biarylpiperidine and 2,2-biarylmorpholine
BR9805265A (en) Precipitated silicas that contain an active substance.
JO2369B1 (en) Novel cyclohexyl sulphones
NO984950L (en) Compounds with growth hormone releasing properties
NO20014240L (en) C16-unsaturated FP-selective prostaglandin analogs
HU9503270D0 (en) Nipecotic acid derivatives as antithrombic compounds
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
BR9812780A (en) 2-aryl-3-aroilbenzo [b] thiophenes useful for the treatment of estrogen loss syndrome
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
DE69812438D1 (en) COMPOSITION FOR THE PRODUCTION OF FUEL BRIQUETTES
MX9603348A (en) Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase.
AU2207801A (en) Substances
EP1004716A3 (en) Insulation panel
AU2003294405A1 (en) Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
ATE194915T1 (en) INTRANASALES ANTIMIGRAINE MEDICINE
WO2001010422A3 (en) Use of hepoxilins or hepoxilin analogs as antidiabetics, antiinframmatory agents
DK0713485T3 (en) Thiocarbamoyl compounds as microbicides
MX9603133A (en) Parahydrophenylacetic acid for insecticide repellency reduction.